La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

PW Medtech Group Salute del bilancio

Salute finanziaria criteri di controllo 6/6

PW Medtech Group ha un patrimonio netto totale di CN¥4.8B e un debito totale di CN¥0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥5.2B e CN¥327.1M. L'EBIT di PW Medtech Group è CN¥191.8M rendendo il suo rapporto di copertura degli interessi -4.4. Ha liquidità e investimenti a breve termine pari a CN¥1.6B.

Informazioni chiave

Rapporto debito/patrimonio netto

CN¥0

Debito

Indice di copertura degli interessi	-4.4x
Contanti	CN¥1.59b
Patrimonio netto	CN¥4.82b
Totale passività	CN¥327.06m
Totale attività	CN¥5.15b

Aggiornamenti recenti sulla salute finanziaria

We Think PW Medtech Group (HKG:1358) Can Manage Its Debt With Ease

Nov 23

Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly

Dec 28

Recent updates

How Much Have PW Medtech Group (HKG:1358) Shareholders Earned On Their Investment Over The Last Five Years?

Feb 18

Should You Rely On PW Medtech Group's (HKG:1358) Earnings Growth?

Jan 23

Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly

Dec 28

Should You Be Adding PW Medtech Group (HKG:1358) To Your Watchlist Today?

Dec 10

What You Need To Know About PW Medtech Group Limited's (HKG:1358) Investor Composition

Nov 22

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CN¥2.0B ) di 1358 superano le sue passività a breve termine ( CN¥149.3M ).

Passività a lungo termine: Le attività a breve termine di 1358 ( CN¥2.0B ) superano le sue passività a lungo termine ( CN¥177.8M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 1358 è esente da debiti.

Riduzione del debito: 1358 non ha debiti rispetto a 5 anni fa, quando il suo rapporto debito/patrimonio netto era 12.6%.

Copertura del debito: 1358 non ha debiti, pertanto non deve essere coperto dal flusso di cassa operativo.

Copertura degli interessi: 1358 non ha debiti, pertanto la copertura dei pagamenti degli interessi non è un problema.

PW Medtech Group Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

We Think PW Medtech Group (HKG:1358) Can Manage Its Debt With Ease

Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly

Recent updates

PW Medtech Group Limited to Report First Half, 2024 Results on Aug 30, 2024

Now 21% overvalued after recent price rise

Upcoming dividend of HK$0.05 per share

Executive Chairman & CEO recently sold HK$53k worth of stock

Here's Why PW Medtech Group Limited's (HKG:1358) CEO Might See A Pay Rise Soon

PW Medtech Group Limited (SEHK:1358) announces an Equity Buyback for HKD 150 million worth of its shares.

PW Medtech Group Limited, Annual General Meeting, Jun 14, 2024

Full year 2023 earnings released: EPS: CN¥0.098 (vs CN¥0.068 in FY 2022)

PW Medtech Group Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

There's Reason For Concern Over PW Medtech Group Limited's (HKG:1358) Price

Upcoming dividend of HK$0.049 per share at 11% yield

PW Medtech Group Limited Announces Interim (Semi-Annual) Dividend for the Six Months Ended 30 June 2023, Payable on October 24, 2023

PW Medtech Group Limited Announces Interim (Semi-Annual) Dividend for the Six Months Ended 30 June 2023, Payable on October 24, 2023

PW Medtech Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023

PW Medtech Group Limited to Report First Half, 2023 Results on Aug 31, 2023

New minor risk - Market cap size

Full year 2022 earnings released: EPS: CN¥0.068 (vs CN¥0.47 in FY 2021)

We Think PW Medtech Group (HKG:1358) Can Manage Its Debt With Ease

First half 2022 earnings released: EPS: CN¥0.039 (vs CN¥0.48 in 1H 2021)

PW Medtech Group Limited Announces Executive Changes

PW Medtech Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

PW Medtech Group Limited to Report First Half, 2022 Results on Aug 31, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

PW Medtech Group Limited, Annual General Meeting, Jun 08, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

PW Medtech Group Limited (SEHK:1358) agreed to acquire 51.5% stake in Beijing Ruijian High-Tech Biological Technology Co., Ltd from a group of shareholders for CNY 412 million.

First half 2021 earnings released: EPS CN¥0.48 (vs CN¥0.09 in 1H 2020)

Investor sentiment improved over the past week

Independent Non-Executive Director Xingdong Zhang has left the company

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.40 (vs CN¥0.052 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.40 (vs CN¥0.052 in FY 2019)

PW Medtech Group Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

How Much Have PW Medtech Group (HKG:1358) Shareholders Earned On Their Investment Over The Last Five Years?

New 90-day low: HK$0.52

Should You Rely On PW Medtech Group's (HKG:1358) Earnings Growth?

New 90-day high: HK$2.31

CITIC Capital Holdings Limited completed the acquisition of 2.4% stake in China Biologic Products Holdings, Inc. (NasdaqGS:CBPO) from PW Medtech Group Limited (SEHK:1358).

Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly

Should You Be Adding PW Medtech Group (HKG:1358) To Your Watchlist Today?

New 90-day high: HK$2.29

What You Need To Know About PW Medtech Group Limited's (HKG:1358) Investor Composition

Market bids up stock over the past week

CITIC Capital Holdings Limited entered into an agreement to acquire 2.4% stake in China Biologic Products Holdings, Inc. (NasdaqGS:CBPO) from PW Medtech Group Limited (SEHK:1358) for approximately $110 million.

New 90-day high: HK$1.76

First half earnings released

PW Medtech Group Limited to Report First Half, 2020 Results on Aug 27, 2020

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane